<DOC>
	<DOCNO>NCT01390051</DOCNO>
	<brief_summary>The purpose study investigate treatment anticoagulant drug increase birth weight pregnancy complicate fetal growth restriction .</brief_summary>
	<brief_title>Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight ?</brief_title>
	<detailed_description>Clinical purpose : 1 . To examine whether treatment low molecular weight heparin pregnant woman Intrauterine Growth Restriction ( IUGR ) increase birth weight child . Our hypothesis increase birth weight lead reduce morbidity mortality among child . Laboratory purpose : 1 . To evaluate three new method monitor effect LMWH . 2 . To investigate 2 biochemical marker positive predictor IUGR IUGR define foetus grows less expect . IUGR estimate occur 5 % pregnancy , IUGR second common cause perinatal morbidity mortality . Thus , 75 % stillbirth cause IUGR . IUGR diagnose ultrasonography . In IUGR uteroplacental blood flow often compromise result foetal growth restriction . Design : The study prospective randomise study pregnant woman suspect severe IUGR randomise either treatment Innohep® treatment . Half woman receive Innohep® half woman receive treatment . Endpoints The primary endpoint difference birth weight child born woman receive Innohep® pregnancy child born woman receive Innohep® pregnancy</detailed_description>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Tinzaparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . Singleton pregnancy 2 . IUGR show ultrasonography : 3 . Can understand read Danish 1 . Age 18 year 2 . Pregestational weight &lt; 90 kilogram 3 . Not able give inform consent 4 . Chronic kidney disease creatinine &gt; 150 μmol/l 5 . Chronic hypertension blood pressure &gt; 140/90 mmHg 6 . Diabetes mellitus ; type 1 2 gestational diabetes 7 . Inflammatory bowel disease 8 . Severe heart disease ( include mechanical heart valve ) 9 . Drug alcohol abuse 10 . Known coagulopathy ( von Willebrand disease , thrombocytopenia , carrier haemophilia ) 11 . Treatment vitamin K antagonists 12 . Known allergy low LMWH 13 . Previous heparininduced thrombocytopenia ( HIT ( type II ) ) 14 . Clinically significant bleeding within last month 15 . Women indication prophylactic treatment LMWH pregnancy e.g . previous thromboembolic disease serious type thrombophilia ( deficiency antithrombin , protein C protein S ) 16 . Chromosome anomaly child 17 . Severe malformation child 18 . Contraindication Innohep® 19 . Gestational week &gt; 32 week</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>birth weight</keyword>
	<keyword>thrombosis</keyword>
	<keyword>anticoagulant therapy</keyword>
</DOC>